[Treatment of painful diabetic neuropathies].
Strian
F
F
Neurologische Ambulanz, Max-Planck-Institut für Psychiatrie, München.
Haslbeck
M
M
Standl
E
E
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003929:Diabetic Neuropathies / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009407:Nerve Block / Q000379:methods; D009437:Neuralgia / Q000209:etiology / Q000628:therapy*
D000700:Analgesics; D000701:Analgesics, Opioid; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002220:Carbamazepine
Behandlung schmerzhafter Diabetesneuropathien.